Assessing Sarcopenia in Advanced‐Stage Ovarian Cancer Patients Undergoing Neoadjuvant Chemotherapy: A Case Series
Ovarian cancer patients with low muscle mass during neoadjuvant chemotherapy may not be identified as sarcopenic based on the EWGSOP2 diagnostic algorithm. While lacking a universally accepted definition for cancer-related sarcopenia and cancer-specific recommendations for the screening, diagnosis, and treatment of sarcopenia, ovarian cancer clinicians should focus on the diagnosis and treatment of low muscle mass and density.
Authors
- C. M. J. Peddle-McIntyre
- Robert Usher Newton (ORCID: https://orcid.org/0000-0003-0302-6129)
- Paul A. Cohen (ORCID: https://orcid.org/0000-0002-4860-9232)
- Christelle Schofield (ORCID: https://orcid.org/0000-0001-6322-0287)
- Daniel A. Galvão (ORCID: https://orcid.org/0000-0002-8209-2281)
- Tarek Meniawy (ORCID: https://orcid.org/0000-0002-1457-6137)
- Dennis R. Taaffe (ORCID: https://orcid.org/0000-0001-6381-1597)
- Jin‐Soo Kim (ORCID: https://orcid.org/0000-0002-6038-6182)
Institutions
- Edith Cowan University (AU)
- St John of God Subiaco Hospital (AU)
- The University of Western Australia (AU)
- Sir Charles Gairdner Hospital (AU)
- St John of God Hospital (AU)
Publication Details
- Journal
- Cancer Reports
- Published
- 2024-08-01
- DOI
- https://doi.org/10.1002/cnr2.2155
- Primary Topic
- Nutrition and Health in Aging
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Australian Government
- Edith Cowan University